Student Spotlight

Greene Stephen CMDBIMG 0259

Stephen Greene, DDS

Entered: 2013
BS, Florida A&M; DDS, Howard University

Welcome to the Cell, Molecular, and Developmental Biology (CMDB) PhD Theme, a part of the Graduate Biomedical Sciences program at the University of Alabama at Birmingham School of Medicine. The CMDB theme is designed to provide maximum flexibility that results in students who are prepared to launch into a career in the emerging biomedical science field. Our graduates have exciting careers in scientific research in both academic and industrial settings; scientific-related writing, business, law, bioterrorism, forensics, administration, and education. 

About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.

About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.

Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
No events found
GCalendar
  • Combined measurements of brain anatomy, connectivity and neurochemistry distinguish autism spectrum disorder subjects from controls.Rajesh Kana and Lauren LiberoIn an ancient Indian parable, a group of blind men touches different parts of a large animal to find what it is. Only when they share the descriptions of an ear, tail, trunk and leg do they know it is an elephant. Rajesh Kana, Ph.D., of the University of Alabama at Birmingham has brought a similar approach to the classification, and eventual diagnosis, of autism. Kana and colleagues are the first to combine three different measures of the brain — anatomy, the connectivity between different brain regions, and levels of a neurochemical — to distinguish people with autism spectrum disorder (ASD) from matched, typically developing peers. This multimodal approach, published online this week in the journal “Cortex,” is distinct from many previous studies that have used a single neuroimaging measure. While those studies...

  • Previous research indicated six weeks of treatment improved hearing, but new findings published in the New England Journal of Medicine reveal six months is better.Babies treated for symptomatic cytomegalovirus (CMV) infection for six months, instead of the standard six weeks, have better hearing and developmental outcomes, according to a new study from the University of Alabama at Birmingham. One in 150 babies will be born with CMV, and about one of every five of those children will develop permanent hearing loss or have developmental disabilities, according to the Centers for Disease Control and Prevention. CMV is the most common infection passed from a mother to her unborn child, and there is no vaccine or cure for it. David Kimberlin, M.D., professor and co-director of the UAB Division of Pediatric Infectious Diseases at Children’s of Alabama and president of the Pediatric Infectious Diseases Society, and colleagues from about 30 other academic medical centers...

  • The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid. The University of Alabama at Birmingham has launched two studies of cannabidiol oil, or CBD oil, as a treatment for severe, intractable seizures. The two studies, an adult study at UAB and a pediatric study at Children’s of Alabama, were authorized by the Alabama Legislature in 2014 by legislation known as Carly’s Law. The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid. “We are extremely pleased to launch these exciting studies,” said David Standaert, M.D., Ph.D., chair of the Department of Neurology. “What we learn from these investigations could have a profound impact on...

Epi Menu